[1]李锴,岳新灿,王常伟,等.高分级动脉瘤性蛛网膜下腔出血治疗时机与临床预后的相关性[J].中国临床神经外科杂志,2023,28(12):696-700.[doi:10.13798/j.issn.1009-153X.2023.12.007]
　LI Kai,YUE Xin-can,WANG Chang-wei,et al.Correlation between timing of treatment and clinical prognosis of patients with high-grade aneurysmal subarachnoid hemorrhage[J].,2023,28(12):696-700.[doi:10.13798/j.issn.1009-153X.2023.12.007]
点击复制

高分级动脉瘤性蛛网膜下腔出血治疗时机与临床预后的相关性()
分享到：

《中国临床神经外科杂志》[ISSN:1009-153X/CN:42-1603/TN]

卷:
28
期数:
2023年12期
页码:
696-700
栏目:
论著
出版日期:
2023-12-31

文章信息/Info

Title:
Correlation between timing of treatment and clinical prognosis of patients with high-grade aneurysmal subarachnoid hemorrhage
文章编号:
1009-153X（2023）12-0696-05
作者:
李锴; 岳新灿; 王常伟; 刘霄; 史鹏飞; 何兵; 赵余涛; 刘德中
466000河南，周口市中心医院神经外科（李锴、岳新灿、王常伟、刘霄、史鹏飞、何兵、赵余涛、刘德中）
Author(s):
LI Kai;  YUE Xin-can;  WANG Chang-wei;  LIU Xiao;  Shi Peng-fei;  HE Bing;  ZHAO Yu-tao;  LIU De-zhong
Department of Neurosurgery, Zhoukou Central Hospital, Zhoukou Henan466000
关键词:
高分级动脉瘤性蛛网膜下腔出血; 迟发性脑缺血; 预后; 治疗时机
Keywords:
High-grade aneurysmal subarachnoid hemorrhage;  Delayed cerebral ischemia;  Prognosis;  Treatment timing
分类号:
R 743.9; R 651.1+2
DOI:
10.13798/j.issn.1009-153X.2023.12.007
文献标志码:
A
摘要:
目的 探讨高分级（Hunt-Hess分级4-5级）动脉瘤性蛛网膜下腔出血（aSAH）治疗时机与临床预后的关系。方法 回顾性分析2018年1月至2022年1月收治的81例高分级aSAH的临床资料。术后随访3个月，根据临床表现或CT检查诊断迟发性脑缺血（DCI），采用改良Rankin量表（mRS）评分评估预后，其中3~5分为预后不良。结果 81例中，显微夹闭术治疗36例，血管内栓塞治疗45例；发病3 d内治疗54例，发病3~10 d治疗23例，发病>10 d治疗4例。术后随访3个月，32例发生DCI（39.5%，32/81），其中夹闭术和血管内治疗的DCI发生率分别为41.7%（15/36）和37.8%（17/45）；46例（46/81，56.8%）预后不良。多因素logistic回归分析显示，发病3~10 d接受治疗的病人DCI风险明显增高（OR=2.88；95% CI 1.03~8.00；P=0.043）。单因素分析显示治疗时机、年龄>55岁和脑室内出血量>30 ml与术后3个月预后不良有关（P<0.05）；亚组分析显示，年龄>55岁（OR=23.26；95% 1.63~332.25；P=0.020）、合并急性脑积水（OR=9.29；95% CI 1.06~81.27；P=0.044）或脑室内出血（OR=7.43；95% CI 1.72~32.12；P=0.007）的病人，发病3~10 d接受治疗预后不良风险明显增加。结论 高分级aSAH病人发病3~10 d接受动脉瘤治疗可能与较差的预后相关。对于55岁以上、有急性脑积水或脑室内出血的病人，应尽早干预。
Abstract:
Objective To investigate the relationship between the timing of treatment and clinical outcomes in patients with high-grade (Hunt-Hess grades 4-5) aneurysmal subarachnoid hemorrhage (aSAH). Methods A retrospective analysis was conducted on 81 patients with high-grade aSAH admitted to our hospital from January 2018 to January 2022. Three months after surgery, delayed cerebral ischemia (DCI) was diagnosed based on clinical manifestations or CT findings, and the modified Rankin Scale (mRS) score was used to evaluate outcomes, with a score of 3~5 indicating poor prognosis. Results Of the 81 patients, 36 patients underwent microsurgical clipping and 45 underwent endovascular embolization. Treatment was initiated within 3 days of onset in 54 patients, between 3~10 days in 23 patients, and after 10 days in 4 patients. Thirty-two patients (39.5%, 32/81) had DCI, with DCI rates of 41.7% (15/36) and 37.8% (17/45) in the clipping and coiling groups, respectively. A total of 46 patients (56.8%) had poor outcomes. Multivariate logistic regression analysis showed a significantly increased risk of DCI in patients receiving treatment between 3~10 days of onset (OR=2.88; 95% CI 1.03-8.00; P=0.043). Univariate analysis indicated that treatment timing, age >55 years, and intraventricular hemorrhage volume >30 ml were associated with poor outcomes at 3 months after surgery (P<0.05). Subgroup analysis revealed that patients >55 years old (OR=23.26; 95% CI 1.63-332.25; P=0.020) and those with acute hydrocephalus (OR=9.29; 95% CI 1.06-81.27; P=0.044) or intraventricular hemorrhage (OR=7.43; 95% CI 1.72-32.12; P=0.007) had a significantly increased risk of poor outcomes when treated between 3~10 days of onset. Conclusions Treatment of high-grade aSAH within 3~10 days of onset may be associated with worse outcomes. Early intervention is recommended for patients over 55 years old with acute hydrocephalus or intraventricular hemorrhage.

参考文献/References:

[1]RAN KR, WANG AC, NAIR SK, et al. Acute multidisciplinary management of aneurysmal subarachnoid hemorrhage（aSAH) [J]. Balkan Med J, 2023, 40(2): 74-81.
[2]徐跃峤，石广志，魏俊吉，等. 重症动脉瘤性蛛网膜下腔出血管理专家共识（2023）[J]. 中国脑血管病杂志，2023，20（2）：126-144，封3.
[3]陈少伟，黄国河，蔡刚峰. 超早期介入栓塞治疗动脉瘤性蛛网膜下腔出血的疗效观察[J]. 深圳中西医结合杂志， 2022，32（23）：72-74.
[4]SANTOS AN, NII-AMON-KOTEI DN, DINGER TF, et al. Impact of treatment timing on the risk of cerebral infarction in patients with aneurysmal subarachnoid hemorrhage [J]. World Neurosurg, 2022, 168: e97-e109.
[5]STURIALE CL, AURICCHIO AM, STIFANO V, et al. Timing and outcome of bystanders treatment in patients with subarachnoid hemorrhage associated with multiple aneurysms [J]. Neurosurg Rev, 2022, 45(4): 2837-2844.
[6]MASSON A, BOULOUIS G, JANOT K, et al. Acute hydrocephalus and delayed cerebral infarction after aneurysmal subarachnoid hemorrhage [J]. Acta Neurochir（Wien), 2022, 164(9): 2401-2408.
[7]WINBERG J, HOLM I, CEDERBERG D, et al. Cerebral microdialysis-based interventions targeting delayed cerebral ischemia following aneurysmal subarachnoid hemorrhage [J]. Neurocrit Care, 2022, 37(1): 255-266.
[8]MITTAL AM, PEASE M, MCCARTHY D, et al. Hunt-Hess score at 48 hours improves prognostication in Grade 5 aneurysmal subarachnoid hemorrhage [J]. World Neurosurg, 2023, 171: e874-e878.
[9]SCHMIDT TP, WEISS M, HOELLIG A, et al. Revisiting the timeline of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage: toward a temporal risk profile [J]. Neurocrit Care, 2022, 37(3): 735-743.
[10]NIZNICK N, SAIGLE V, MARTI ML, et al. Patient relevance of the modifiedRankin scalein subarachnoid hemorrhage research: an international cross-sectional survey [J]. Neurology, 2023, 100(15): e1565-e1573.
[11]胥　凯，韩　超，丁守銮，等. 181例高分级动脉瘤性蛛网膜下腔出血病人术前再出血的影响因素[J]. 山东大学学报（医学版），2022，60（9）：97-101.
[12]DORHOUT MEES SM, MOLYNEUX AJ, KERR RS, et al. Timing of aneurysm treatment after subarachnoid hemorrhage: relationship with delayed cerebral ischemia and poor outcome [J]. Stroke, 2012, 43(8): 2126~2129.

相似文献/References:

[1]李朝晖　王玉贵　张孟超 综述　赵兴利 审校.CT灌注成像在动脉瘤性蛛网膜下腔出血中的 临床应用进展[J].中国临床神经外科杂志,2016,(05):313.[doi:10.13798/j.issn.1009-153X.2016.05.021]
[2]王世龙,赵　冬,许　晖,等.血脂水平与动脉瘤性蛛网膜下腔出血后迟发性脑缺血的相关性[J].中国临床神经外科杂志,2016,(11):685.[doi:10.13798/j.issn.1009-153X.2016.11.011]
　WANG Shi-long,ZHAO Dong,XU Hui,et al.Relationship of serum lipid with delayed cerebral ischemia following the aneurysmal subarachnoid hemorrhage[J].,2016,(12):685.[doi:10.13798/j.issn.1009-153X.2016.11.011]
[3]张林峰　周小兵　黄鑫根　丁　聪　汪　阳.CT灌注成像在动脉瘤性蛛网膜下腔出血中的应用[J].中国临床神经外科杂志,2022,27(04):311.[doi:10.13798/j.issn.1009-153X.2022.04.024]
[4]姜海洋,陈虎,郭星,等.动脉瘤性蛛网膜下腔出血病人Lindegaard比值与脑组织氧分压的相关性[J].中国临床神经外科杂志,2022,27(08):640.[doi:10.13798/j.issn.1009-153X.2022.08.005]
　JIANG Hai-yang,CHEN Hu,GUO Xing,et al.Relationship between Lindegaard ratio and brain tissue oxygen tension in patients with aneurysmal subarachnoid hemorrhage[J].,2022,27(12):640.[doi:10.13798/j.issn.1009-153X.2022.08.005]
[5]付宏亮,景文记,卢俊义.血清miR-149-3p和CXCR3水平与aSAH后迟发性脑缺血的相关性分析[J].中国临床神经外科杂志,2023,28(01):11.[doi:10.13798/j.issn.1009-153X.2023.01.004]
　FU Hong-liang,JING Wen-ji,LU Jun-yi.Correlation of serum levels of miR-149-3p and CXCR3 with delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage[J].,2023,28(12):11.[doi:10.13798/j.issn.1009-153X.2023.01.004]
[6]刘健伟,程矫,甄勇,等.术后早期脑电双频指数对高分级动脉瘤性蛛网膜下腔出血病人意识恢复的预测价值[J].中国临床神经外科杂志,2023,28(08):493.[doi:10.13798/j.issn.1009-153X.2023.08.005]
　LIU Jian-wei,CHENG Jiao,ZHEN Yong,et al.Value of early postoperative bispectral index in predicting consciousness recovery of patients with poor-grade aneurysmal subarachnoid hemorrhage[J].,2023,28(12):493.[doi:10.13798/j.issn.1009-153X.2023.08.005]
[7]李荔荣,王景春,张福龙,等.血清ET-1水平与动脉瘤性蛛网膜下腔出血后迟发性脑缺血的关系[J].中国临床神经外科杂志,2023,28(10):643.[doi:10.13798/j.issn.1009-153X.2023.10.010]
　LI Li-rong,WANG Jing-chun,ZHANG Fu-long,et al.Relationship between serum ET-1 level and delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage[J].,2023,28(12):643.[doi:10.13798/j.issn.1009-153X.2023.10.010]

备注/Memo

备注/Memo:
（2023-08-04收稿，2023-08-24修回）
通讯作者：刘德中，E-mail：ly0099168@163.com
更新日期/Last Update: 2023-12-31